Zhengye Biotechnology Holding (ZYBT) Accounts Payables (2023 - 2025)

Zhengye Biotechnology Holding has reported Accounts Payables over the past 3 years, most recently at $55974.1 for Q4 2025.

  • Quarterly Accounts Payables fell 92.84% to $55974.1 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $55974.1 through Dec 2025, down 92.84% year-over-year, with the annual reading at $6.3 million for FY2025, 718.73% up from the prior year.
  • Accounts Payables was $55974.1 for Q4 2025 at Zhengye Biotechnology Holding, down from $58000.0 in the prior quarter.
  • Over five years, Accounts Payables peaked at $781974.7 in Q4 2024 and troughed at $55974.1 in Q4 2025.
  • The 3-year median for Accounts Payables is $87402.1 (2023), against an average of $253188.3.
  • Year-over-year, Accounts Payables skyrocketed 569.47% in 2024 and then crashed 92.84% in 2025.
  • A 3-year view of Accounts Payables shows it stood at $116804.3 in 2023, then skyrocketed by 569.47% to $781974.7 in 2024, then crashed by 92.84% to $55974.1 in 2025.
  • Per Business Quant, the three most recent readings for ZYBT's Accounts Payables are $55974.1 (Q4 2025), $58000.0 (Q2 2025), and $781974.7 (Q4 2024).